BANVT.E — Banvit Bandirma Vitaminli Yem Sanayi AS Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeSmall CapSucker Stock

Market Cap
TRY15.00bn
Enterprise Value
TRY12.57bn
Revenue
TRY33.49bn

Annual income statement for Banvit Bandirma Vitaminli Yem Sanayi AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	R2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,321	20,274	30,789	41,275	33,492
Cost of Revenue
Gross Profit	680	-516	3,653	9,673	945
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	5,144	22,563	30,317	35,031	36,767
Operating Profit	178	-2,289	471	6,244	-3,275
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	118	-938	2,034	6,736	-2,906
Provision for Income Taxes
Net Income After Taxes	95.2	-952	1,446	4,711	-3,115
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	95.2	-983	1,374	4,711	-3,115
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	95.2	-983	1,374	4,711	-3,115
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.12	-9.52	14.5	46.4	-26.6
Dividends per Share